Iradimed (IRMD) Shares Outstanding (2013 - 2026)

Iradimed (IRMD) has 14 years of Shares Outstanding data on file, last reported at $12.8 million in Q1 2026.

• Quarterly Shares Outstanding rose 0.53% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (up 0.53% YoY) and the FY2025 annual result came in at $12.8 million, up 0.57% from the prior year.
• Shares Outstanding steadied at $12.8 million in Q1 2026 per IRMD's latest filing, from $12.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $12.8 million in Q1 2026 and bottomed at $12.6 million in Q1 2022.
• The 5-year median for Shares Outstanding is $12.7 million (2024), against an average of $12.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding increased 2.02%; it then climbed 0.27% in 2023.
• Tracing IRMD's Shares Outstanding over 5 years: stood at $12.6 million in 2022, then gained by 0.55% to $12.7 million in 2023, then climbed by 0.39% to $12.7 million in 2024, then grew by 0.57% to $12.8 million in 2025, then increased by 0.01% to $12.8 million in 2026.
• Per Business Quant, the three latest IRMD Shares Outstanding figures stand at $12.8 million (Q1 2026), $12.8 million (Q4 2025), and $12.7 million (Q3 2025).

Peer Comparison